68. BBVA Spark Opens Up; Doubts on SICC’s US$2bn Pharma ‘’Investment’’; S&P Cuts Outlook; GAP Explains

Rodrigo Velasco, Head of BBVA Spark Mexico & LatAm, discusses how BBVA’s division for fast-growing, tech-oriented companies and funds works in practice, and what he looks for when taking on a new client, extending credit or investing in a VC fund.

First, Eduardo and Damian dissect the news of the week:

* S&P moves Mexico’s outlook to negative while keeping the rating at BBB.

* Ebrard prepares markets for a USMCA review without a clean endpoint.

* Alejandro Werner warns on Mexico’s low-growth model.

* SICC’s US$2bn Hidalgo pharma MOU — and why investors may be skeptical.

* GAP shifts from airport operator to broader infrastructure platform.

* Tourism weakness hits hotels

* Braskem Idesa faces an operational and financial crisis.

* Bunq applies for a Mexican banking license.